Home > Investor Centre > ASX Announcements

ASX Announcements

30 Oct 2024	Webinar recording with CEO Paul Long

29 Oct 2024	Ceasing to be a substantial holder

28 Oct 2024	Investor webinar invitation and investor presentation

28 Oct 2024	Ceasing to be a substantial holder

25 Oct 2024	Change in substantial holding from Tiga Trading Pty Ltd

25 Oct 2024	Investor webinar invitation

17 Oct 2024	Quarterly Activities Report and Appendix 4C

17 Oct 2024	Cleansing Notice

17 Oct 2024	Application for quotation of securities - LGP

06 Sep 2024	Change of Director's Interest Notice x 2

03 Sep 2024	Notification regarding unquoted securities - LGP

29 Aug 2024	Results of Annual General Meeting

08 Aug 2024	Addendum to Notice of Annual General Meeting

25 Jul 2024	Investor Presentation

24 Jul 2024	Letter to Shareholders regarding Annual General Meeting

24 Jul 2024	Notice of Annual General Meeting

24 Jul 2024	Change of Registered Office and Principal Place of Business

22 Jul 2024	Quarterly Activities Report and Appendix 4C

22 Jul 2024	Change in FY2024 AGM date

22 Jul 2024	Notification of cessation of securities - LGP

10 Jul 2024	Change in BDO Auditor entity

31 May 2024	Corporate Governance Statement and Appendix 4G
	Corporate Governance Statement and Appendix 4G

31 May 2024	Appendix 4E and 2024 Annual Report
	Little Green Pharma Ltd is pleased to share its 2024 Annual Report to Shareholders.

02 May 2024	US Reschedules Cannabis

29 Apr 2024	Investor Webinar & Presentation March 2024 Quarterly Reports

17 Apr 2024	Quarterly Activities Report & Appendix 4C

16 Apr 2024	Change of Director's Interest Notice x 2

16 Apr 2024	Application for quotation of securities - LGP

16 Apr 2024	Application for quotation of securities - LGP

16 Apr 2024	Notification regarding unquoted securities - LGP

16 Apr 2024	Notification of cessation of securities - LGP

03 Apr 2024	Application for quotation of securities - LGP

28 Feb 2024	First Polish Shipment

26 Feb 2024	Germany Legalises Cannabis

21 Feb 2024	Results of General Meeting and appointment of auditor

19 Feb 2024	Final Appendix 3A.5

19 Feb 2024	Reset Offers withdrawn and Reset to remain LGP subsidiary

08 Feb 2024	Investor Webinar & December Quarterly Results Presentation

01 Feb 2024	LGP receives $5 million R&D rebate

31 Jan 2024	Quarterly Activities Report & Appendix 4C

17 Jan 2024	Updated Appendix 3A.5

17 Jan 2024	Extension of Reset Offers and change of General Meeting date

11 Jan 2024	Reset sponsored WA Psilocybin Clinical Trial Opens

04 Jan 2024	Updated Appendix 3A.5

04 Jan 2024	Reset Offers extension and change of General Meeting date

12 Dec 2023	Updated Appendix 3A.5

11 Dec 2023	Change of date of General Meeting and Reset Offers

07 Dec 2023	LGP to capitalise on new French cannabis healthcare laws

30 Nov 2023	CEO Update on Financial Results

30 Nov 2023	Half Yearly Financial Presentation

30 Nov 2023	Half Yearly Report and Accounts

21 Nov 2023	Reset Mind Sciences Investor Webinar

20 Nov 2023	Reset Mind Sciences - Investor Presentation

17 Nov 2023	Reset Mind Sciences Offers Open

10 Nov 2023	Letter to Shareholders regarding Demerger & Priority Offer

10 Nov 2023	Long Form Prospectus

10 Nov 2023	Short Form Prospectus

10 Nov 2023	Letter to Shareholders regarding Notice of General Meeting

10 Nov 2023	Notice of General Meeting

10 Nov 2023	Appendix 3A.5

10 Nov 2023	Correction of Defective Cleansing Notice

31 Oct 2023	Quarterly Activities Report & Appendix 4C

04 Oct 2023	Change of Director's Interest Notice x 5

27 Sep 2023	Cleansing notice

27 Sep 2023	Application for quotation of securities - LGP

27 Sep 2023	Notification regarding unquoted securities - LGP

27 Sep 2023	Application for quotation of securities - LGP

27 Sep 2023	Application for quotation of securities - LGP

18 Sep 2023	Change of registry address notification

07 Sep 2023	Large scale cannabis study findings released

30 Aug 2023	Annual General Meeting Results Additional Information

29 Aug 2023	Results of Meeting

29 Aug 2023	AGM Presentation and Company Update

16 Aug 2023	Change in Leadership at Little Green Pharma

02 Aug 2023	Desert Flame granted Polish Marketing Authorisation

01 Aug 2023	Notification of cessation of securities - LGP

01 Aug 2023	Application for quotation of securities - LGP

01 Aug 2023	Change in substantial holding

01 Aug 2023	Change in substantial holding

31 Jul 2023	Letter to Shareholders regarding Annual General Meeting

28 Jul 2023	Notice of Annual General Meeting

28 Jul 2023	Quarterly Activities Report & Appendix 4C

14 Jul 2023	Change of Director's Interest Notice x 3

14 Jul 2023	Application for quotation of securities - LGP

12 Jul 2023	LGP Awarded French trial tender for CBD50

07 Jul 2023	Notification of cessation of securities - LGP

07 Jul 2023	Application for quotation of securities - LGP

07 Jul 2023	Application for quotation of securities - LGP

07 Jul 2023	AGM date and closing date for director nominations

03 Jul 2023	Reset Mind Sciences signs long-term property lease

30 Jun 2023	Annual Report to shareholders

30 Jun 2023	Corporate Governance Statement and Appendix 4G

31 May 2023	Preliminary Final Report

08 May 2023	LGP wins extended French government tender

01 May 2023	Change of Director's Interest Notice x 4

27 Apr 2023	Quarterly Activities Report & Appendix 4C

24 Apr 2023	Application for quotation of securities - LGP

24 Apr 2023	Application for quotation of securities - LGP

24 Apr 2023	Notification regarding unquoted securities - LGP

24 Apr 2023	Notification of cessation of securities - LGP

17 Apr 2023	First shipment to Ilios Sante in Germany

31 Mar 2023	Change in substantial holding - Tiga Trading Pty Ltd

31 Mar 2023	Cleansing notice

31 Mar 2023	Application for quotation of securities - LGP

24 Mar 2023	Proposed issue of securities - LGP

24 Mar 2023	Proposed issue of securities - LGP

24 Mar 2023	Successful completion of $5 million placement

22 Mar 2023	Trading Halt

22 Mar 2023	Reset Mind Sciences and HIF enter Strategic Alliance

15 Mar 2023	Change in substantial holding - Tiga Trading Pty Ltd

06 Mar 2023	Change of Director's Interest Notice x 4

27 Feb 2023	Cleansing notice

27 Feb 2023	Notification regarding unquoted securities - LGP

27 Feb 2023	Application for quotation of securities - LGP

27 Feb 2023	Notification regarding unquoted securities - LGP

27 Feb 2023	Application for quotation of securities - LGP

15 Feb 2023	Ethics approval granted for psilocybin clinical trial

08 Feb 2023	Ceasing to be a substantial holder

06 Feb 2023	Psilocybin and MDMA down-scheduled

02 Feb 2023	Amended Constitution

31 Jan 2023	Results of Meeting

19 Jan 2023	Notification regarding unquoted securities - LGP

19 Jan 2023	Results of Share Purchase Plan

19 Jan 2023	Application for quotation of securities - LGP

16 Jan 2023	Quarterly Activities Report & Appendix 4C

13 Jan 2023	Notification of cessation of securities - LGP

30 Dec 2022	Change in substantial holding

29 Dec 2022	Letter to Shareholders regarding General Meeting

29 Dec 2022	Notice of General Meeting

19 Dec 2022	Share Purchase Plan offer extended to 16 January 2023

14 Dec 2022	Corrected Appendix 3B

14 Dec 2022	Correction to Announcement and Appendix 3B

02 Dec 2022	Second exclusive supply agreement with Cannamedical

30 Nov 2022	Ethics approval for CBD Phase III clinical trial

30 Nov 2022	Half Yearly Report and Accounts

25 Nov 2022	LGP wins National Export Award for International Health

24 Nov 2022	LGP significantly expands flower portfolio

22 Nov 2022	Change in substantial holding

21 Nov 2022	Letter to Shareholders for Share Purchase Plan

21 Nov 2022	Prospectus

21 Nov 2022	Share Purchase Plan open to eligible shareholders

21 Nov 2022	Update Four 20 Pharma and French trial extension

10 Nov 2022	Change in substantial holding

09 Nov 2022	Cleansing Notice

09 Nov 2022	Application for quotation of securities - LGP

09 Nov 2022	Correction to Appendix 3Y

02 Nov 2022	Proposed issue of securities - LGP

02 Nov 2022	Proposed issue of securities - LGP

02 Nov 2022	LGP announces $4 million placement and $2 million SPP

31 Oct 2022	Quarterly Activities Report & Appendix 4C

31 Oct 2022	Trading Halt

25 Oct 2022	Notice of change in auditor

06 Oct 2022	Notification of cessation of securities - LGP

06 Oct 2022	Change in substantial holding

04 Oct 2022	Exclusive supply agreement with Cannamedical in Germany

28 Sep 2022	TGA advertising infringement notices

06 Sep 2022	Amended Constitution

06 Sep 2022	Change of Director's Interest Notice x 4

06 Sep 2022	Notification regarding unquoted securities - LGP

06 Sep 2022	Application for quotation of securities - LGP

30 Aug 2022	Results of Meeting

29 Aug 2022	AGM Company Update

17 Aug 2022	Notice of Release from Escrow

02 Aug 2022	Notification of cessation of securities - LGP

29 Jul 2022	Letter to Shareholders regarding Annual General Meeting

29 Jul 2022	Notice of Annual General Meeting

27 Jul 2022	Quarterly Activities Report & Appendix 4C

21 Jul 2022	Change of Director's Interest Notice

20 Jul 2022	Notification regarding unquoted securities - LGP

20 Jul 2022	Application for quotation of securities - LGP

20 Jul 2022	Notification of cessation of securities - LGP

20 Jul 2022	Application for quotation of securities - LGP

15 Jul 2022	AGM Date and Closing Date for Director Nominations

13 Jul 2022	Change in substantial holding

12 Jul 2022	LGP signs $2M supply agreement with Ilios Sante

07 Jul 2022	Initial Director's Interest Notice

07 Jul 2022	Former Bayer Regulatory & Quality Director joins LGP Board

01 Jul 2022	Corporate Governance Statement and Appendix 4G

01 Jul 2022	Annual Report to shareholders

06 Jun 2022	Company Update Presentation

31 May 2022	Preliminary Final Report

19 May 2022	Exclusive supply contract for new high-THC strain in Germany

09 May 2022	Cleansing Notice

09 May 2022	Application for quotation of securities - LGP

02 May 2022	LGP Signs Key UK Supply Agreement

29 Apr 2022	Quarterly Activities Report & Appendix 4C

19 Apr 2022	LGP Denmark Signs Major Sales Agreement with Demecan

14 Mar 2022	Change of Director's Interest Notice

07 Mar 2022	Cleansing Notice

07 Mar 2022	Application for quotation of securities - LGP

28 Feb 2022	Half Yearly Report and Accounts

18 Feb 2022	Application for quotation of securities - LGP

18 Feb 2022	LGP Wins Italian Tender

10 Feb 2022	Notice of Release from Escrow

08 Feb 2022	Intention to Demerge Psychedelics Business

02 Feb 2022	Company Update Presentation

27 Jan 2022	Quarterly Activities Report & Appendix 4C

21 Jan 2022	Exclusive Distribution Agreement for LGP Medicines in Greece

19 Jan 2022	Exclusive Cannabis Oils Distribution Agreement in Germany

07 Dec 2021	Application for quotation of securities - LGP

01 Dec 2021	Change in substantial holding

01 Dec 2021	Change in substantial holding

23 Nov 2021	First Registration for Produced Cannabis Medicine in Denmark

22 Nov 2021	Results of Meeting

29 Oct 2021	Jobkeeper Payments FY2021 & FY2020

27 Oct 2021	Investor Presentation

27 Oct 2021	Investor Presentation

27 Oct 2021	Quarterly Activities Report & Appendix 4C

27 Oct 2021	Quarterly Activities Report & Appendix 4C

25 Oct 2021	Presentation at South-West Connect ASX Showcase

15 Oct 2021	Letter to Shareholders regarding Annual General Meeting

15 Oct 2021	Notice of Annual General Meeting

29 Sep 2021	Annual Report to shareholders

29 Sep 2021	Appendix 4G and Corporate Governance Statement

08 Sep 2021	Change of Director's Interest Notice x 2

07 Sep 2021	LGP expands into Psychedelic Medicines

06 Sep 2021	First Danish Shipment to Australia, Key Appointments

06 Sep 2021	AGM Date and Closing Date for Director Nominations

06 Sep 2021	Notification regarding unquoted securities - LGP

31 Aug 2021	Preliminary Final Report

31 Aug 2021	Preliminary Final Report

18 Aug 2021	Change of Director's Interest Notice x 2

17 Aug 2021	Cleansing Notice

17 Aug 2021	Application for quotation of securities - LGP

17 Aug 2021	Notification regarding unquoted securities - LGP

17 Aug 2021	Application for quotation of securities - LGP

17 Aug 2021	Notification regarding unquoted securities - LGP

28 Jul 2021	Quarterly Activities Report & Appendix 4C

19 Jul 2021	Results of Meeting

07 Jul 2021	Change in substantial holding

06 Jul 2021	Becoming a substantial holder

06 Jul 2021	Investor Webinar - Denmark Acquisition

05 Jul 2021	Change in substantial holding

02 Jul 2021	Change in substantial holding - Tiga Trading Pty Ltd

01 Jul 2021	Becoming a substantial holder

01 Jul 2021	Cleansing Notice

01 Jul 2021	Investor Presentation

30 Jun 2021	Application for quotation of securities - LGP

22 Jun 2021	Proposed issue of securities - LGP

22 Jun 2021	Investor Presentation - Denmark acquisition & capital raise

22 Jun 2021	LGP acquires Denmark facility and undertakes share placement

21 Jun 2021	Trading Halt

17 Jun 2021	Exclusive distribution partner - leading Polish pharma group

17 Jun 2021	Letter to Shareholders regarding General Meeting

17 Jun 2021	Notice of General Meeting

15 Jun 2021	Update to Sales and Distribution in Australia and Germany

10 Jun 2021	Becoming a substantial holder - Tiga Trading Pty Ltd

28 May 2021	Results of Meeting

27 May 2021	$2.5m firm order increases expected DEMECAN revenue to $5.7m

28 Apr 2021	Quarterly Activities Report & Appendix 4C

27 Apr 2021	Letter to Shareholders regarding General Meeting

27 Apr 2021	Notice of Extraordinary General Meeting

20 Apr 2021	LGP agrees Danish Distribution Agreement with Balancial

23 Mar 2021	Ceasing to be a substantial holder

15 Mar 2021	Proposed issue of Securities - LGP

15 Mar 2021	Firm purchase order from Demecan and acquisition of land

12 Mar 2021	Change of Director's Interest Notice x 4

12 Mar 2021	Appendix 3G - employee share rights

12 Mar 2021	Cleansing Notice

12 Mar 2021	Appendix 2A - incentive shares & conversion of share rights

12 Mar 2021	Appendix 2A - shares for services

12 Mar 2021	Appendix 2A - conversion of Performance Rights

12 Mar 2021	Appendix 2A - Share Purchase Plan shares

11 Mar 2021	LGP delivers first French shipment

08 Mar 2021	LGP Completes Successful $5 Million SPP

08 Mar 2021	LGP Completes Successful $5 Million SPP

01 Mar 2021	Change in substantial holding

01 Mar 2021	Change in substantial holding

24 Feb 2021	Company Update and Presentation of Half Yearly Results

24 Feb 2021	Half Yearly Report and Accounts

24 Feb 2021	Half Yearly Report and Accounts

18 Feb 2021	Large Scale Cannabis Study Launched

18 Feb 2021	Large Scale Cannabis Study Launched

15 Feb 2021	Appendix 2A - issue of placement shares & cleansing notice

15 Feb 2021	Share Purchase Plan Offer Booklet

09 Feb 2021	Cleansing Notice

09 Feb 2021	Proposed issue of Securities - LGP

09 Feb 2021	LGP secures firm commitments to raise $22 million

08 Feb 2021	Appendix 2A

08 Feb 2021	Appendix 2A - exercise of options

05 Feb 2021	Appendix 2A - release of shares from escrow

05 Feb 2021	LGP exports first commercial shipment to Germany

05 Feb 2021	Trading Halt

29 Jan 2021	Quarterly Activities Report & Appendix 4C

28 Jan 2021	Notice of release from escrow

27 Jan 2021	LGP wins French government tender

12 Jan 2021	Appendix 2A - options exercise & cleansing notice

17 Dec 2020	Change of Director's interest notice x 4

17 Dec 2020	Appendix 2A - options exercise & cleansing notice

17 Dec 2020	Appendix 2A

17 Dec 2020	Appendix 3G

17 Dec 2020	Issue of securities approved at AGM

16 Dec 2020	TGA announces final CBD down-scheduling decision

26 Nov 2020	Results of Annual General Meeting

26 Nov 2020	Company Update to the AGM

19 Nov 2020	First Australian Medicinal Cannabis Oils Exported to Germany

10 Nov 2020	Proposed issue of Securities - LGP

10 Nov 2020	LGP enters strategic partnership with HIF

10 Nov 2020	Trading Halt

10 Nov 2020	Proposed issue of Securities - LGP

27 Oct 2020	Letter to Shareholders regarding Annual General Meeting

27 Oct 2020	Notice of Annual General Meeting

26 Oct 2020	Appendix 2A - Exercise of Options and Cleansing Notice

26 Oct 2020	Quarterly Activities Report & Appendix 4C

21 Oct 2020	Becoming a substantial holder- Tiga Trading Pty Ltd

14 Oct 2020	Little Green Pharma granted GMP Licence

07 Oct 2020	Appendix 2A - Release from Escrow

02 Oct 2020	AGM Date and Closing Date for Director Nominations

30 Sep 2020	Notice of release from escrow

22 Sep 2020	TGA Medicinal Cannabis Post Market Survey

10 Sep 2020	LGP welcomes proposed CBD down-scheduling

04 Sep 2020	Change in substantial holding

31 Aug 2020	Appendix 4G

31 Aug 2020	2020_Annual Report to shareholders

28 Aug 2020	Appendix 2A and Cleansing Notice

28 Aug 2020	Proposed issue of Securities - LGP

26 Aug 2020	Appendix 2A and Cleansing Notice

14 Aug 2020	Appendix 2A - Exercise of Options and Cleansing Notice

03 Aug 2020	Appendix 2A - Release from Escrow

24 Jul 2020	Change in substantial holding

24 Jul 2020	Notice of Release from Escrow

23 Jul 2020	Investor Update Webinar

22 Jul 2020	Investor Presentation

22 Jul 2020	July 2020_Quarterly Activities Report and Appendix 4C

20 Jul 2020	Medicinal Cannabis Permit Granted for Expanded Facility

01 Jul 2020	Appendix 2A - Exercise of Options and Cleansing Notice

01 Jul 2020	Appendix 2A - Release from Escrow

01 Jul 2020	Notice of Release from Escrow

01 Jul 2020	Change of Company Secretary

29 Jun 2020	Strategic Shipment Exported to the UK

28 May 2020	Sales Update - April 2020

13 May 2020	Clarification Statement

11 May 2020	ODC Manufacturing Permit Granted

08 May 2020	Proposed issue of Securities - LGP

30 Apr 2020	Investor Presentation

30 Apr 2020	March 2020_Quarterly Activities Report and Appendix 4C

30 Apr 2020	Virtual Conference

15 Apr 2020	First UK Shipment of Australian Medicinal Cannabis Oil

02 Apr 2020	COVID-19 Business Update

26 Mar 2020	Commissioning of Cultivation Facility Expansion Complete

16 Mar 2020	Investor Presentation

12 Mar 2020	Expanded Medicinal Licence and new Manufacturing Licence

02 Mar 2020	Fourth Medicinal Cannabis Oil Product

28 Feb 2020	Appendix 4D and Half Yearly Report

27 Feb 2020	German Purchase Agreement with Demecan

26 Feb 2020	Becoming a substantial holder - Elixxer Ltd

25 Feb 2020	Becoming a substantial holder - FS

21 Feb 2020	Initial Director's Interest Notice - AC

21 Feb 2020	Initial Director's Interest Notice - FS

21 Feb 2020	Initial Director's Interest Notice - NF

21 Feb 2020	Initial Director's Interest Notice - MLB

19 Feb 2020	Binding Purchase Agreement with UK-Based Astral Health

19 Feb 2020	Confirmation Statements

19 Feb 2020	Top 20 Holders

19 Feb 2020	Distribution Schedule

19 Feb 2020	Securities Trading Policy

19 Feb 2020	Corporate Governance Statement

19 Feb 2020	Employee Incentive Plan Terms

19 Feb 2020	Updated Pro-Forma Balance Sheet

19 Feb 2020	Financial Statements - 30 June 2019

19 Feb 2020	Financial Statements - 30 June 2018

19 Feb 2020	Constitution

19 Feb 2020	Supplementary Prospectus

19 Feb 2020	Prospectus

19 Feb 2020	Appendix 1A and Information Form and Checklist

19 Feb 2020	ASX Notice - Admission to Official List